Puberty blockers—technically called gonadotropin-releasing hormone analogues (GnRHas) and approved mainly for use in precocious (early) puberty—work by temporarily pausing development in ...

At least one Michigan health system is halting gender-affirming services for young patients, following an executive order ...

One of the main treatments for CPP is the use of gonadotropin-releasing hormone analogs (GnRHa), which help to delay the progression of puberty and can positively influence final adult height ...

England's National Health Service banned the use of puberty blockers for children seeking treatment for gender dysphoria, ...

Medroxyprogesterone should be used to treat the unpleasant hot flashes that some men experience as a result of androgen suppression therapy for prostate cancer. Such is the recommendation of ...